HR 61 by McKinnor
HR 61
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This resolution recognizes September 2025 as Sickle Cell Disease Awareness Month in California. It calls for increased awareness and public knowledge of the disease, which disproportionately affects African-Americans and other populations. The resolution encourages state support for outreach, education, research, treatment, and monitoring related to sickle cell disease, and proposes the development of screening programs to improve access to care and genetic testing opportunities.
Key provisions
- Designates September 2025 as Sickle Cell Disease Awareness Month in California.
- Encourages state funding for sickle cell disease-related initiatives (outreach, education, research, treatment, and monitoring).
- Promotes the development of sickle cell disease screening programs.
- Suggests the implementation of genetic testing referrals within screening programs.
- Calls for increased public knowledge of sickle cell disease.
- Acknowledges the disproportionate impact of the disease on African-Americans in California.
- Highlights barriers to care faced by sickle cell disease patients, including access to treatment and discrimination.
- References evidence-based clinical guidelines for emergency room treatment of sickle cell crises.
Who is affected
- African-Americans
- Individuals with Sickle Cell Disease
- Caregivers of individuals with Sickle Cell Disease
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours